Genzyme Expands Immunology Portfolio Through Sangstat Acquisition
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 39 (Table of Contents)
Published: 1 Aug-2003
DOI: 10.3833/pdr.v2003.i39.874 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Genzyme entered into agreement to acquire Sangstat Medical Corporation thereby substantially expanding its immunology product portfolio in the area of organ transplantation...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS